High-dose albumin treatment for acute ischaemic stroke (ALIAS) part 2: a randomised, double-blind, phase 3, placebo-controlled trial
Authors:
- Myron D GinsbergMyron D Ginsberg
- Yuko Y PaleschYPYuko Y Palesch
- Michael D HillMHMichael D Hill
- Renee H MartinRMRenee H Martin
- Claudia S MoyCMClaudia S Moy
- William G BarsanWBWilliam G Barsan
- Bonnie D WaldmanBWBonnie D Waldman
- Diego TamarizDTDiego Tamariz
- Karla J RyckborstKRKarla J Ryckborst
- 1 November 2013
- journal article
- research article
- Published by Elsevier in The Lancet Neurology
- Vol. 12 (11) , 1049-1058
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Albumin Therapy Enhances Collateral Perfusion after Laser-Induced Middle Cerebral Artery Branch Occlusion: A Laser Speckle Contrast Flow StudyJournal of Cerebral Blood Flow & Metabolism, 2012
- Stroke research at a crossroad: asking the brain for directionsNature Neuroscience, 2011
- The Albumin in Acute Stroke Part 1 TrialStroke, 2011
- The Albumin in Acute Stroke (ALIAS) Multicenter Clinical TrialStroke, 2011
- Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical useThe Lancet Neurology, 2009
- Neuroprotection for ischemic stroke: Past, present and futureNeuropharmacology, 2008
- Albumin Therapy Augments the Effect of Thrombolysis on Local Vascular Dynamics in a Rat Model of Arteriolar ThrombosisStroke, 2008
- Albumin Therapy Improves Local Vascular Dynamics in a Rat Model of Primary Microvascular ThrombosisStroke, 2008
- 1,026 Experimental treatments in acute strokeAnnals of Neurology, 2006
- Interim Monitoring of Group Sequential Trials Using Spending Functions for the Type I and Type II Error ProbabilitiesDrug Information Journal, 2001